FAAH
Fatty-acid amide hydrolase 1
As of the edition of 20 October 2026, FAAH (fatty-acid amide hydrolase 1, UniProt O00519) has 3 drugs tested at it and 20 companies on the list, 1 on route A and 3 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- O00519
- How well studied
- Chemical tools exist; no approved drug acts on it
- Where it sits in the cell
- In more than one place
- Disease areas
- Nervous system; Cancer; Immune system; Bones, joints and muscles; Infections; Heart and blood vessels; Urinary and reproductive; Nutrition and metabolism
- Registered trials of its drugs
- 840
Drugs at this target
| Status | Count |
|---|---|
| Marketed | 1 |
| Active | 1 |
| Stopped | 1 |
| Total | 3 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Acetaminophen | Marketed | Phase 4 | none listed |
| JNJ-42165279 | Active | Phase 2 | none listed |
| Redafamdastat | Stopped | Phase 2 | none listed |
3 of 3 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Route A | 1 |
| Route B | 3 |
| Engaged | 15 |
| Undetermined | 1 |
| Total on the list | 20 |
| Company | Route |
|---|---|
| Pfizer | Route A |
| Sanofi | Route B |
| Johnson & Johnson | Route B |
The other 17 companies at FAAH
In the product20 companies in all; 17 are not named here, and no score is.
See the 20 companies at FAAH, ranked, with the facts behind eachRequest access. Nothing is shown until you do.